Assets intended for use by media professionals.
These images are downloadable for non-commercial use and for purposes such as news reporting or research. The images may not be modified and must display the following copyright language: Copyright © 2009-2016 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, N.J., U.S.A. All rights reserved.
For more information on Merck’s copyright and trademark policies, please click here.
For general media inquiries only, please call +1 908-740-5633 or e-mail Media Relations. Members of the media seeking information on a specific topic may also contact the following individuals:
Title: Enterprise Social Media
Office Phone: +1 267-305-1158
Email: elizabeth.cooney@merck.com
Title: Product, Pipeline & Supply Media Relations
Office Phone: +1 267-305-3558
Email: pamela_eisele@merck.com
Title: Corporate Media Relations
Office Phone: +1 908-608-4859
Email: jessica.fine@merck.com
For consumer or patient-related questions, please contact your physician, pharmacist or other health care provider.
To report an adverse experience with a specific Merck product, please call the Merck National Service Center at +1 800-672-6372.
If you are a physician, pharmacist or other health care provider and have a question(s) or need information about a specific Merck product or service, please call the Merck National Service Center for Health Care Professionals at +1 866-448-7590.
Tel: +1 800-522-9114
Monday-Friday, 7AM – 7 PM CST
Tel: +1 908-423-5881
Monday-Friday, 8:30 AM – 4 PM ET
From developing new therapies that treat and prevent disease to helping people in need, we're committed to improving health and well-being around the world. Visit our About Us section.
Connect with us on Facebook, Twitter, and LinkedIn to learn more about our corporate initiatives, including those in health and wellness, philanthropy and corporate responsibility.
Elizabeth Cooney, Social Media +1 267-305-1158 Elizabeth.Cooney@merck.com
Copyright © 2009- Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. All rights reserved.
This website of Merck & Co., Inc., Kenilworth, NJ, USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.
Risks and uncertainties include, but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and healthcare legislation in the United States and internationally; global trends toward healthcare cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.
The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2015 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov).
The information contained in this website was current as of the date presented. The company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date.
Merck, known as MSD outside the United States and Canada, is a leading research-driven healthcare company.